Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)

Detalles Bibliográficos
Autores principales: Yeroushalmi, Samuel, Chung, Mimi, Bartholomew, Erin, Hakimi, Marwa, Koo, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563208/
https://www.ncbi.nlm.nih.gov/pubmed/36248199
http://dx.doi.org/10.1016/j.jdin.2022.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563208/
https://www.ncbi.nlm.nih.gov/pubmed/36248199
http://dx.doi.org/10.1016/j.jdin.2022.08.010

Ejemplares similares